Cargando…

Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury

Ischemia/reperfusion injury is the leading cause of acute tubular necrosis. Nitric oxide has a protective role against ischemia/reperfusion injury; however, the role of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, in ischemia/reperfusion injury remains unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakayama, Yosuke, Ueda, Seiji, Yamagishi, Sho-ichi, Obara, Nana, Taguchi, Kensei, Ando, Ryotaro, Kaida, Yusuke, Iwatani, Ryuji, Kaifu, Kumiko, Yokoro, Miyuki, Toyonaga, Maki, Kusumoto, Takuo, Fukami, Kei, Okuda, Seiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944656/ https://www.ncbi.nlm.nih.gov/pubmed/24107853 http://dx.doi.org/10.1038/ki.2013.398

Ejemplares similares

RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice
por: Taguchi, Kensei, et al.
Publicado: (2018)

DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
por: Kaida, Yusuke, et al.
Publicado: (2013)

L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis
por: Tashiro, Kyoko, et al.
Publicado: (2017)

Association between asymmetric dimethylarginine and sarcopenia in community-dwelling older women
por: Yokoro, Miyuki, et al.
Publicado: (2023)

Correction to: Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus
por: Shibata, Ryo, et al.
Publicado: (2022)

Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus
por: Shibata, Ryo, et al.
Publicado: (2022)

Involvement of Iron-Evoked Oxidative Stress in Smoking-Related Endothelial Dysfunction in Healthy Young Men
por: Fukami, Kei, et al.
Publicado: (2014)

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients
por: Fukami, Kei, et al.
Publicado: (2014)

Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients
por: Koike, Kiyomi, et al.
Publicado: (2016)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

RAGE signaling regulates the progression of diabetic complications
por: Taguchi, Kensei, et al.
Publicado: (2023)

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
por: Ishibashi, Yuji, et al.
Publicado: (2014)

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
por: Fukami, Kei, et al.
Publicado: (2014)

A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023)

The Coexistence of Multiple Myeloma-associated Amyloid Light-chain Amyloidosis and Fabry Disease in a Hemodialysis Patient
por: Taguchi, Kensei, et al.
Publicado: (2017)

Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
por: Taguchi, Kensei, et al.
Publicado: (2021)

Encapsulating Peritoneal Sclerosis in a Patient Receiving Peritoneal Dialysis and Glucocorticoid Therapy
por: Taguchi, Kensei, et al.
Publicado: (2023)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)

Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
por: Szabo, Zsuzsanna, et al.
Publicado: (2020)

Dysregulation of dimethylargininedimethylaminohydrolase/asymmetric dimethylarginine pathway in rat type II diabetic nephropathy
por: Lai, Ying-Ling, et al.
Publicado: (2012)

Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration
por: Alkaitis, Matthew S., et al.
Publicado: (2015)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA)
por: Arlouskaya, Yana, et al.
Publicado: (2019)

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
por: Xie, Ziang, et al.
Publicado: (2022)

Efficacy of Combination Therapy with Telmisartan Plus Amlodipine in Patients with Poorly Controlled Hypertension
por: Bekki, Hisatoshi, et al.
Publicado: (2010)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Variability of Symmetric Dimethylarginine in Apparently Healthy Dogs
por: Kopke, M.A., et al.
Publicado: (2018)

Variability of symmetric dimethylarginine in apparently healthy dogs
por: Baral, Randolph M., et al.
Publicado: (2018)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

Dimethylarginines in Children after Anti-Neoplastic Treatment
por: Jezierska, Michalina, et al.
Publicado: (2022)

Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients
por: Yamagishi, Sho-ichi, et al.
Publicado: (2016)

Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: Tommasi, S., et al.
Publicado: (2017)

Nitric oxide, asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in psychotic exacerbation of schizophrenia and bipolar disorder manic episode
por: Ustundag, Mehmet F., et al.
Publicado: (2020)

Exploring the role of dimethylarginine dimethylaminohydrolase-mediated reduction in tissue asymmetrical dimethylarginine levels in cardio-protective mechanism of ischaemic postconditioning in rats
por: Kaur, Kamaldeep, et al.
Publicado: (2019)

Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD
por: Schou-Pedersen, Anne Marie Voigt, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m1bs9un6adkg23rj9rd4sdq8s2